Panzara Michael A.
SEC insider (Form 3/4/5 filer). CIK 0001679039. Director at LeonaBio, Inc. (LONA) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in BOTHELL, WA.
Companies Panzara Michael A. has filed insider reports for
- LeonaBio, Inc. (LONA): Director
- IMMUNIC, INC. (IMUX): Officer, Chief Medical Officer
Panzara Michael A.
CIK: 0001679039
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 23, 2026LONA
LeonaBio, Inc.
AwardDirectStock Option (Right to Buy)
28K shares- - Apr 24, 2026IMUX
IMMUNIC, INC.
AwardDirectStock Option
300K shares- - Apr 9, 2026LONA
LeonaBio, Inc.
AwardDirectStock Option (Right to Buy)
28K shares- - May 30, 2025ATHA
Athira Pharma, Inc.
AwardDirectStock Option (Right to Buy)
20.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 |  LONA LeonaBio, Inc. | Award Stock Option (Right to Buy) | 28,000 | - | - | Direct |
| Apr 24, 2026 |  IMUX IMMUNIC, INC. | Award Stock Option | 300,000 | - | - | Direct |
| Apr 9, 2026 | LONA LeonaBio, Inc. | Award Stock Option (Right to Buy) | 28,000 | - | - | Direct |
| May 30, 2025 |  ATHA Athira Pharma, Inc. | Award Stock Option (Right to Buy) | 20,900 | - | - | Direct |
1-4 of 4 transactions